Research Warns AI Giants Are Deploying Tobacco and Pharma-Style 'Corporate Capture' Tactics to Resist Regulation

A new academic report has found that major artificial intelligence companies are employing the same regulatory influence techniques historically used by the tobacco, oil, and pharmaceutical industries to shape — and resist — government oversight. The research, which includes contributions from Dr Abeba Birhane, director of Trinity College Dublin's AI Accountability Lab, identifies 'corporate capture' as the dominant mechanism: a process by which regulatory frameworks and public bodies come to act in the interest of corporations rather than the public. The most prevalent tactic identified was 'narrative capture' — systematic attempts by AI companies to influence the position of public officials and regulators through framing. Specific examples cited include the repeated deployment of arguments that 'regulation stifles innovation' and that 'red tape can stymie national interest' to justify resisting oversight. The researchers also found evidence of contentious interpretations of antitrust, privacy, copyright, and labour laws by large AI firms. For UK and EU legal practitioners, the findings carry direct relevance. The EU AI Act — the world's first comprehensive AI regulatory framework — is currently in its implementation and transition phases, with high-risk AI system providers facing compliance deadlines. The research suggests that AI companies' lobbying strategies may be shaping how those rules are being interpreted and enforced in practice, raising questions for legal advisers about the robustness of the regulatory architecture their clients are building compliance programmes around. The report represents an important input for lawyers advising on AI governance, regulatory strategy, and compliance frameworks, particularly as firms are themselves increasingly deploying AI tools whose regulatory exposure sits within this contested policy space.